DARCIS, Gilles ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses - médecine interne
SAUVAGE, Anne-Sophie ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses - médecine interne
FRIPPIAT, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses - médecine interne
MEURIS, Christelle ; Centre Hospitalier Universitaire de Liège - CHU > Direction médicale > Hygiène Hospitalière
UURLINGS, Françoise ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Centre de référence VIH/SIDA
LECOMTE, Marianne ; Centre Hospitalier Universitaire de Liège - CHU > Service des maladies infectieuses - médecine interne
LEONARD, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Clinique de médecine des voyageurs
GIOT, Jean-Baptiste ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses - médecine interne
fombellida, karine
VAIRA, Dolorès ; Centre Hospitalier Universitaire de Liège - CHU > Unilab > Unité de laboratoire - LRS Biomol
MOUTSCHEN, Michel ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses - médecine interne
Language :
English
Title :
Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017.
UNAIDS. Ending AIDS: progress towards the 90-90-90 targets, http://www.unaids.org/sites/default/files/media-asset/Global-AIDS-update-2017-en.pdf.
Quinn, T. C. et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 342, 921-929 (2000).
Fleishman, J. A., Yehia, B. R., Moore, R. D., Gebo, K. A. & Network, H. I. V. R. The economic burden of late entry into medical care for patients with HIV infection. Med Care 48, 1071-1079 (2010).
Lanoy, E. et al. Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther 12, 89-96 (2007).
Castilla, J. et al. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr 40, 96-101 (2005).
Smit, C., Hallett, T. B., Lange, J., Garnett, G. & de Wolf, F. Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands. PLoS One 3, e1949 (2008).
May, M. T. et al. Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study. Clin Infect Dis 62, 1571-1577 (2016).
Robbins, G. K. et al. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis 48, 350-361 (2009).
Group, I. S. S. et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med 373, 795-807 (2015).
Molina, J. M. et al. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial. Lancet HIV (2018).
Ananworanich, J. et al. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One 7, e33948 (2012).
Darcis, G., Van Driessche, B. & Van Lint, C. HIV Latency: Should We Shock or Lock? Trends Immunol 38, 217-228 (2017).
Deng, K. et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature 517, 381-385 (2015).
Late presenters working group in, C.i.E. et al. Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro Surveill 20 (2015).
Antinori, A. et al. Late presentation of HIV infection: a consensus definition. HIV Med 12, 61-64 (2011).
The STROBE Statement. University of Bern, https://www.strobe-statement.org/index.php?id=strobe-home (2009).
European AIDS Clinical Society. Guidelines Version 8.2 -January (2017).
Wilson, E. M. & Sereti, I. Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs. Immunol Rev 254, 343-354 (2013).
Barouch, D. H. & Deeks, S. G. Immunologic strategies for HIV-1 remission and eradication. Science 345, 169-174 (2014).
Deeks, S. G. et al. International AIDS Society global scientific strategy: towards an HIV cure 2016. Nat Med 22, 839-850 (2016).
Saez-Cirion, A. et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog 9, e1003211 (2013).
Althoff, K. N. et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis 50, 1512-1520 (2010).
Op de Coul, E. L. et al. Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996-2014: results from a national observational cohort. BMJ Open 6, e009688 (2016).
Helleberg, M. et al. Late presenters, repeated testing, and missed opportunities in a Danish nationwide HIV cohort. Scand J Infect Dis 44, 282-288 (2012).
Jiang, H. et al. Gender difference in advanced HIV disease and late presentation according to European consensus definitions. Sci Rep 5, 14543 (2015).
Alvarez-Del Arco, D. et al. High levels of postmigration HIV acquisition within nine European countries. AIDS 31, 1979-1988 (2017).
Fakoya, I. et al. A systematic review of post-migration acquisition of HIV among migrants from countries with generalised HIV epidemics living in Europe: mplications for effectively managing HIV prevention programmes and policy. BMC Public Health 15, 561 (2015).
Desgrees-du-Lou, A. et al. Sub-Saharan African migrants living with HIV acquired after migration, France, ANRS PARCOURS study, 2012 to 2013. Euro Surveill 20 (2015).
Pannetier, J. et al. Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study. Lancet Public Health 3, e16-e23 (2018).
Alvarez-del Arco, D. et al. HIV testing and counselling for migrant populations living in high-income countries: a systematic review. Eur J Public Health 23, 1039-1045 (2013).
Chin, T., Hicks, C., Samsa, G. & McKellar, M. Diagnosing HIV infection in primary care settings: missed opportunities. AIDS Patient Care STDS 27, 392-397 (2013).
O'Connell, S., Enkelmann, J., Sadlier, C. & Bergin, C. Late HIV presentation - missed opportunities and factors associated with a changing pattern over time. Int J STD AIDS 28, 814-821 (2017).
D'Arminio Monforte, A. et al. HIV-Infected Late Presenter Patients. AIDS Res Treat 2012, 902679 (2012).